Journal of Neuroimmune Pharmacology

Journal of Neuroimmune Pharmacology

J NEUROIMMUNE PHARM
影响因子:3.5
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Springer US
发刊时间:2006
发刊频率:Quarterly
收录数据库:SCIE/Scopus收录
ISSN:1557-1890

期刊介绍

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.
《神经免疫药理学杂志》的宗旨是促进神经系统药理学和免疫学新发现的传播、兴趣和交流。其目标与神经免疫药理学学会的目标相一致,即增加对受免疫系统影响的神经和神经精神疾病的基本了解,反之亦然,并采取药理学措施,以更好地了解疾病机制或改善疾病结局。JNIP的范围包括所有的主要工作和审查的病因学,预防和治疗的神经免疫和神经系统疾病的免疫失调的影响。我们欢迎对环境或内源性信号(如毒素和滥用药物、激素和细胞因子)的神经免疫调节进行原创性研究。JNIP将作为跨学科信息的可靠来源,桥接药理学、免疫学和神经科学领域。
年发文量 56
国人发稿量 18.66
国人发文占比 0.33%
自引率 -
平均录取率-
平均审稿周期 较慢,6-12周
版面费 US$4190
偏重研究方向 医学-神经科学
期刊官网 https://www.springer.com/11481
投稿链接 https://www.editorialmanager.com/jnip

期刊高被引文献

Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09873-y
Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09853-2
Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09851-4
Targeting the Dopaminergic System in Autoimmunity
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09834-5
Resveratrol (3, 5, 4′-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09842-5
Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09884-9
Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09835-4
Intranasal Delivery of lincRNA-Cox2 siRNA Loaded Extracellular Vesicles Decreases Lipopolysaccharide-Induced Microglial Proliferation in Mice
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09864-z
HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09869-8
Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09875-w
Stem Cell Extracellular Vesicles and their Potential to Contribute to the Repair of Damaged CNS Cells
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09865-y
Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09848-z
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-018-09831-0
β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09891-w
Antiretroviral Drugs Promote Amyloidogenesis by De-Acidifying Endolysosomes
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09862-1
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09839-0
Inhibitory Control Deficits Associated with Upregulation of CB1R in the HIV-1 Tat Transgenic Mouse Model of Hand
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09867-w
Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia Cells
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09895-6
Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09854-1
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09852-3
Dopaminergic Agents in Rheumatoid Arthritis
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09850-5
The Role of β-Blockers in Melanoma
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09876-9
Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09856-z
Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09866-x
Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09885-8
Protease Inhibitors, Saquinavir and Darunavir, Inhibit Oligodendrocyte Maturation: Implications for Lysosomal Stress
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09893-8
Involvement of Interferon Regulatory Factor 7 in Nicotine’s Suppression of Antiviral Immune Responses
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09845-2
Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09900-y
Heroin Abuse and/or HIV Infection Dysregulate Plasma Exosomal miRNAs
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09892-9
Dopaminergic Pathways in Obesity-Associated Inflammation
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09863-0
The Association of Immune Markers with Cognitive Performance in South African HIV-Positive Patients
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09870-1
Protective Effects of 1-Methylnicotinamide on Aβ1–42-Induced Cognitive Deficits, Neuroinflammation and Apoptosis in Mice
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-018-09830-1
Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09897-4
Histamine Induces Microglia Activation and the Release of Proinflammatory Mediators in Rat Brain Via H1R or H4R
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09887-6
Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09883-w
Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson’s Disease
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09888-5
Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09894-7
Hemorrhage Associated Mechanisms of Neuroinflammation in Experimental Traumatic Brain Injury
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09882-x
Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09871-0
Overexpression of TIPE2, a Negative Regulator of Innate and Adaptive Immunity, Attenuates Cognitive Deficits in APP/PS1 Mice
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09861-2
Chronic Intrahippocampal Infusion of HIV-1 Neurotoxic Proteins: A Novel Mouse Model of HIV-1 Associated Inflammation and Neural Stem Cell Dysfunction
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09846-1
Can Our Guts Tell Us Anything About MS?
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09841-6
Haloperidol Reduces the Activity of Complement and Induces the Anti-Inflammatory Transformation of Peritoneal Macrophages in Rats
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09860-3
Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09837-2
Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09872-z
Pre-exposure Prophylaxis Therapy and the Blood-Brain Barrier: Is PrEP Neuroprotective?
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09898-3
Editor’s Commentary for Special Issue: “The Role of Macrophages in HIV Persistence”
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09836-3
Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09881-y
The 25th Scientific Conference of the Society on Neuroimmune Pharmacology: Program and Abstracts
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09847-0
Successful Treatment of Long Standing Complex Regional Pain Syndrome with Hyperbaric Oxygen Therapy
来源期刊:Journal of Neuroimmune PharmacologyDOI:10.1007/s11481-019-09901-x

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
92.86%31.25%-5.41%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
NEUROSCIENCES
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
NEUROSCIENCES 神经科学
3区
PHARMACOLOGY & PHARMACY 药学
3区
2023年12月升级版
医学3区
NEUROSCIENCES 神经科学
3区
PHARMACOLOGY & PHARMACY 药学
3区
2022年12月旧的升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
2区
NEUROSCIENCES 神经科学
3区